Rating History for Lineage Cell Therapeutics Inc. (LCTX) by Canaccord
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/28/2026 | John Newman | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.55 (1.16) |
-25.16% | Details |
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/28/2026 | John Newman | New Coverage | Buy (N/A) |
9.00 (N/A) |
1.55 (1.16) |
-25.16% | Details |